These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 380492)

  • 1. Effects of dopamine agonists and antagonists in Tourette's disease.
    Feinberg M; Carroll BJ
    Arch Gen Psychiatry; 1979 Aug; 36(9):979-85. PubMed ID: 380492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gilles de la Tourette's disease and minimal brain dysfunction: amphetamine isomers reveal catecholamine correlates in an affected patient.
    Meyerhoff JL; Snyder SH
    Psychopharmacologia; 1973; 29(3):211-20. PubMed ID: 4512896
    [No Abstract]   [Full Text] [Related]  

  • 3. Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy.
    Pollack MA; Cohen NL; Friedhoff AJ
    Arch Neurol; 1977 Oct; 34(10):630-2. PubMed ID: 269683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome.
    Ross MS; Moldofsky H
    Am J Psychiatry; 1978 May; 135(5):585-7. PubMed ID: 347954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.
    Gianutsos G; Thornburg JE; Moore KE
    Psychopharmacology (Berl); 1976 Nov; 50(3):225-9. PubMed ID: 826966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gilles de la Tourette's syndrome following methylphenidate administration.
    Golden GS
    Dev Med Child Neurol; 1974 Feb; 16(1):76-8. PubMed ID: 4521612
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of endogenous dopamine metabolism in Gilles de la Tourette's disease.
    Messiha FS; Knopp W
    Dis Nerv Syst; 1976 Aug; 37(8):470-3. PubMed ID: 1066216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine autoreceptor stimulation: clinical significance.
    Meltzer HY
    Pharmacol Biochem Behav; 1982; 17 Suppl 1():1-10. PubMed ID: 6223322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Accessory symptomatology and therapy of Gilles de la Tourette's disease].
    Achkova M; Terziev D
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(10):1516-8. PubMed ID: 3480667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provocative drug testing in Tourette's syndrome: d- and l-amphetamine and haloperidol.
    Caine ED; Ludlow CL; Polinsky RJ; Ebert MH
    J Am Acad Child Psychiatry; 1984 Mar; 23(2):147-52. PubMed ID: 6585416
    [No Abstract]   [Full Text] [Related]  

  • 11. Paradoxical response to dopamine agonists in tardive dyskinesia.
    Carroll BJ; Curtis GC; Kokmen E
    Am J Psychiatry; 1977 Jul; 134(7):785-9. PubMed ID: 17308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute effect of haloperidol and apomorphine on the severity of stuttering.
    Burns D; Brady JP; Kuruvilla K
    Biol Psychiatry; 1978 Apr; 13(2):255-64. PubMed ID: 667231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial.
    Goetz CG; Stebbins GT; Thelen JA
    Mov Disord; 1994 May; 9(3):315-7. PubMed ID: 7913738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the locomotor activity effects of apomorphine and the "atypical dopamine agonists" (piribedil and S3608).
    Offermeier J; van Rooyen JM
    Life Sci; 1986 Mar; 38(10):895-903. PubMed ID: 3081774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics.
    Shapiro AK; Shapiro E; Eisenkraft GJ
    Arch Gen Psychiatry; 1983 Nov; 40(11):1235-40. PubMed ID: 6139100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement.
    Devinsky O
    Arch Neurol; 1983 Aug; 40(8):508-14. PubMed ID: 6347142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet dopamine uptake in Huntington's chorea and Gilles de la Tourette's syndrome: effect of haloperidol.
    Butterworth RF; Gonce M; Barbeau A
    Can J Neurol Sci; 1977 Nov; 4(4):285-8. PubMed ID: 145893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications for multiple transmitter mediation of amphetamine-induced stereotypies.
    Cheal M; Kurkulos ME; Silva L
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1305-8. PubMed ID: 6891794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.